Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells

GLIA

Volumn 47, Issue 1, 2004, Pages 9-20

  Pare, Jinseu ^a,b   Choi, Kyungsun ^c   Jeong, Eunjoo ^c   Kwon, Daeho ^b   Benveniste, Etty N ^b   Choi, Chulhee ^b,c  

^a Hallym University   (South Korea)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Ewha Womans University   (South Korea)

Author keywords

Gene regulation; Neuroimmunology; Signal transduction

Indexed keywords

ACETYLCYSTEINE; AMMONIUM CHLORIDE; BAFILOMYCIN A1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CHEMOKINE; CHLOROQUINE; CYTOKINE; DIPHENYLIODONIUM SALT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL;

ACETYLCYSTEINE; ASTROCYTES; BIPHENYL COMPOUNDS; CELLS, CULTURED; CHEMOKINES; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALITIS; HUMANS; INFLAMMATION MEDIATORS; LEUPEPTINS; NF-KAPPA B; ONIUM COMPOUNDS; REACTION TIME; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

EID: 3042837762     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20017     Document Type: Article

References (55)

1. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG. 1997. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272:217-221.
2. Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G. 2001. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 22:147-184.
3. Bruunsgaard H, Pedersen M, Pedersen BK. 2001. Aging and proinflammatory cytokines. Curr Opin Hematol 8:131-136.
4. Buchmuller-Rouiller Y, Corradin SB, Smith J, Mauel J. 1994. Effect of increasing intravesicular pH on nitrite production and leishmanicidal activity of activated macrophages. Biochem J 301:243-247.
5. Cherla RP, Ganju RK. 2001. Stromal cell-derived factor 1α-induced chemotaxis in T cells is mediated by nitric oxide signaling pathways. J Immunol 166:3067-3074.
6. Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahn YS, Kim CH, Kim SJ, Kim JD, Choi IS, et al. 1999. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-α, or IFN-γ. J Immunol 162:1889-1895.
7. Choi C, Xu X, Oh JW, Lee SJ, Gillespie GY, Park H, Jo H, Benveniste EN. 2001. Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res 61:3084-3091.
8. Choi C, Kutsch O, Park J, Zhou T, Seol DW, Benveniste EN. 2002. Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells. Mol Cell Biol 22:724-736.
9. Cross AR, Jones OT. 1986. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem J 237:111-116.
10. Delhase M, Li N, Karin M. 2000. Kinase regulation in inflammatory response. Nature 406:367-368.
11. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. 2002. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med 195: 59-70.
12. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36:180-190.
13. Doussiere J, Vignais PV. 1992. Diphenylene iodonium as an inhibitor of the NADPH oxidase complex of bovine neutrophils. Factors controlling the inhibitory potency of diphenylene iodonium in a cell-free system of oxidase activation. Eur J Biochem 208:61-71.
14. Fagarasan MO, Aisen PS. 1996. IL-1 and anti-inflammatory drugs modulate Aβ cytotoxicity in PC12 cells. Brain Res 723:231-234.
15. Finkel T. 2000. Redox-dependent signal transduction. FEBS Lett 476:52-54.
16. Fox RI. 1993. Mechanism of action of hydroxychloroquine as an anti-rheumatic drug. Semin Arthritis Rheum 23(2 Suppl 1):82-91.
17. +-ATPase. Curr Med Chem 6:1197-1212.
18. Gottlieb E, Vander Heiden MG, Thompson CB. 2000. Bcl-xL prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 20:5680-5689.
19. Hugosson E, Bjorkman A, Troye-Blomberg M. 2002. Chloroquine enhances the number of IL-10 producing cells and the expression of B7-2 and ICAM-1 in in vitro-cultured PBMC. Scand J Immunol 55:399-408.
20. Jeong JY, Jue DM. 1997. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Immunol 158:4901-4907.
21. Johnstone M, Gearing AJ, Miller KM. 1999. A central role for astrocytes in the inflammatory response to β-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol 93:182-193.
22. Jones RW. 2001. Inflammation and Alzheimer's disease. Lancet 358: 436-437.
23. Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18:621-663.
24. Karres I, Kremer JP, Dietl I, Steckholzer U, Jochum M, Ertel W. 1998. Chloroquine inhibits proinflammatory cytokine release into human whole blood. Am J Physiol 274:R1058-1064.
25. Krogstad DJ, Schlesinger PH. 1987. Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. N Engl J Med 317:542-549.
26. Lee SJ, Hou J, Benveniste EN. 1998. Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-κB and C/EBP isoforms. J Neuroimmunol 92:196-207.
27. Li Y, Trush MA. 1998. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 253:295-299.
28. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. 1993. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90:10193-10197.
29. Mayer M, Noble M. 1994. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 91:7496-7500.
30. Murthy CR, Rama Rao KV, Bai G, Norenberg MD. 2001. Ammonia-induced production of free radicals in primary cultures of rat astrocytes. J Neurosci Res 66:282-288.
31. Nakayama K, Furusu A, Xu Q, Konta T, Kitamura M. 2001. Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway. J Immunol 167:1145-1150.
32. O'Neill PM, Bray PG, Hawley SR, Ward SA, Park BK. 1998. 4-Aminoquinolines-past, present, and future: a chemical perspective. Pharmacol Ther 77:29-58.
33. Ornstein MH, Sperber K. 1996. The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis Rheum 39:157-161.
34. Park J, Kwon D, Choi C, Oh J-W, Benveniste EN. 2003. Chloroquine induces activation of nuclear factor-κB and subsequent expression of pro-inflammatory cytokines by human astroglial cells. J Neurochem 84:1266-1274.
35. Pless DD, Wellner RB. 1996. In vitro fusion of endocytic vesicles: effects of reagents that alter endosomal pH. J Cell Biochem 62:27-39.
36. Pullar JM, Hampton MB. 2002. Diphenyleneiodonium triggers the efflux of glutathione from cultured cells. J Biol Chem 277:19402-19407.
37. Ragan CI, Bloxham DP. 1977. Specific labelling of a constituent polypeptide of bovine heart mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone reductase by the inhibitor diphenyleneiodonium. Biochem J 163:605-615.
38. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M, Remacle J. 2001. Development of a sensitive multi-well colorimetric assay for active NF-κB. Nucleic Acids Res 29:E21.
39. Rhee SG. 1999. Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 31:53-59.
40. Salmeron G, Lipsky PE. 1983. Immunosuppressive potential of antimalarials. Am J Med 75:19-24.
41. Schubert P, Morino T, Miyazaki H, Ogata T, Nakamura Y, Marchini C, Ferroni S. 2000. Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann NY Acad Sci 903:24-33.
42. Sperber K, Quraishi H, Kalb TH, Panja A, Stecher V, Mayer L. 1993. Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1α (IL-1α) and IL-6 in human monocytes and T cells. J Rheumatol 20:803-808.
43. Streit WJ, Conde JR, Harrison JK. 2001. Chemokines and Alzheimer's disease. Neurobiol Aging 22:909-913.
44. Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R, Nathan CF. 1991. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5:98-103.
45. 1 raised lysosomal pH and both prodigiosins and concanamycin A inhibited growth through apoptosis. FEBS Lett 537:79-84.
46. van den Borne BE, Dijkmans BA, de Rooij HH, le Cessie S, Verweij CL. 1997. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-α, interleukin 6, and interferon-γ production by peripheral blood mononuclear cells. J Rheumatol 24:55-60.
47. Van Gool WA, Weinstein HC, Scheltens PK, Walstra GJ. 2001. Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet 358:455-460.
48. Van Heerebeek L, Meischl C, Stooker W, Meijer CJLM, Niessen HWM, Roos D. 2002. NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J Clin Pathol 55:561-568.
49. Weber SM, Levitz SM. 2000. Chloroquine interferes with lipopolysaccharide-induced TNF-α gene expression by a nonlysosomotropic mechanism. J Immunol 165:1534-1540.
50. Weber SM, Levitz SM. 2001. Chloroquine antagonizes the proinflammatory cytokine response to opportunistic fungi by alkalizing the fungal phagolysosome. J Infect Dis 183:935-942.
51. Weber SM, Chen JM, Levitz SM. 2002. Inhibition of mitogen-activated protein kinase signaling by chloroquine. J Immunol 168: 5303-5309.
52. Weninger SC, Yankner BA. 2001. Inflammation and Alzheimer disease: the good, the bad, and the ugly. Nat Med 7:527-528.
53. Woodman SE, Benveniste EN, Nath A, Berman JW. 1999. Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes. J Neurovirol 5:678-684.
54. Wu HM, Wen HC, Lin WW. 2002. Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signal-regulating kinase-dependent extracellular signal-related kinase and c-Jun N-terminal kinase activation. Am J Respir Cell Mol Biol 27:234-243.
55. Zafarullah M, Li WQ, Sylvester J, Ahmad M. 2003. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60:6-20.